Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Pancaran Samudera Transport Tbk.: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb), sedangkan Pancaran Samudera Transport Tbk. diperdagangkan di Rp880 (kapitalisasi pasar 1,32 T, volume 24 jam 51,1 rb). Perbedaan utamanya: Pancaran Samudera Transport Tbk. jauh lebih besar — sekitar 8× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (324 rb vs 51,1 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | PSAT | |
|---|---|---|
Kapitalisasi Pasar | 166,01 M | 1,32 T |
Volume | 324 rb | 51,1 rb |
Lot | 3,24 rb | 511 |
Perputaran | 77,68 jt | 45,29 jt |
Harga Rata-rata | 239,75 | 886,35 |
Nilai Transaksi | 77,68 jt | 45,29 jt |
Harga Ekuilibrium Indikatif | 240 | 880 |
Volume Ekuilibrium Indikatif | 1 | 5 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →PT Pancaran Samudera Transport Tbk (the Company) was established on December 10, 2007 in the Republic of Indonesia based on the Notarial Deed No. 1 from Mary Maria, S.H, Notary in Depok. The Company commenced its operations in 2007. The Companys immediate parent company is PT Profitama Hasil Indah, incorporated and domiciled in Indonesia and its ultimate parent company is PT Pancaran Harapan Integra, also incorporated and domiciled in Indonesia.
Selengkapnya di halaman PSAT →